Fig. 3.
MRG15 has a crucial role in resistance to MMC. (A) Survival of U2OS or MCF7 cells pretreated with control or indicated siRNAs determined using a clonogenic assay following treatment with a range of concentrations of MMC. Results are means (± s.d.) of at least three independent experiments. (B) MCF7 cells were treated with control or indicated siRNAs and the levels of endogenous MRG15, PALB2, BRCA2 or α-tubulin (loading control) were analyzed by western blotting. Individual proteins, or a combination of two or three proteins together, were depleted. (C) Survival of MCF7 cells pretreated with control or indicated siRNAs determined using a clonogenic assay following treatment with a range of concentrations of MMC. Cocktails of siRNAs directed against MRG15, MRGX, PALB2 or BRCA2 were used (A-C). Results are means ± s.d. of at least three independent experiments.
